Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy

Seyed-Ali Hosseinian* , Aliakbar Haddad-Mashadrizeh, Samaneh Dolatabadi

Adv Pharm Bull. 2018;8(3): 447-455. doi: 10.15171/apb.2018.052

PMCID: PMC6156485 PMID: 30276141 Scopus ID: 85052601466

Article

PDF

XML

Cited By:

2

1

2

Research Article

2. Novel Methotrexate-Ciprofloxacin Loaded Alginate-Clay Based Nanocomposite as Anticancer and Antibacterial Co-Drug Delivery System

Mehrdad Mahkam , Fatemeh Bazmi Zeynabad, Effat Alizadeh, Mahdi Rahimi, Fariborz Rahimi* , Roya Salehi*

Adv Pharm Bull. 2021;11(3): 477-489. doi: 10.34172/apb.2021.055

PMCID: PMC8421626 PMID: 34513622 Scopus ID: 85108902176

Article

PDF

Full Text

XML

Cited By:

3

2

13

Research Article

3. Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice

Amir Daei Farshchi Adli, Rana Jahanban-Esfahlan, Khaled Seidi, Davoud Farajzadeh, Ramezan Behzadi, Nosratollah Zarghami*

Adv Pharm Bull. 2021;11(2): 385-392. doi: 10.34172/apb.2021.037

PMCID: PMC8046391 PMID: 33880362 Scopus ID: 85103213880

Article

PDF

Full Text

XML

Cited By:

2

4

2

Research Article

4. Melanoma Cancer Therapy Using PEGylated Nanoparticles and Semiconductor Laser

Abdorreza Asrar , Zahra Sobhani , Mohammad Ali Behnam*

Adv Pharm Bull. 2022;12(3): 524-530. doi: 10.34172/apb.2022.055

PMCID: PMC9348541 PMID: 35935047 Scopus ID: 85140274726

Article

PDF

Full Text

XML

Cited By:

0

1

7

Review Article

5. mRNA as a Therapeutics: Understanding mRNA Vaccines

Ferdi Oğuz , Harika Atmaca*

Adv Pharm Bull. 2022;12(2): 274-282. doi: 10.34172/apb.2022.028

PMCID: PMC9106950 PMID: 35620336 Scopus ID: 85128230280

Article

PDF

Full Text

XML

Cited By:

0

1

1

Review Article

6. Biosynthesis of Quantum Dots and Their Therapeutic Applications in the Diagnosis and Treatment of Cancer and SARS-CoV-2

Musa Moetasam Zorab , Navid Mohammadjani, Morahem Ashengroph* , Mehran Alavi*

Adv Pharm Bull. 2023;13(3): 411-422. doi: 10.34172/apb.2023.065

PMCID: PMC10460808 PMID: 37646053

Article

PDF

Full Text

XML

Cited By:

0

2

Review Article

7. Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor

Adnan Rehmatullah Siddique* , Geeta Sameer Bhagwat

Adv Pharm Bull. 2024;14(1): 132-146. doi: 10.34172/apb.2023.080

PMCID: PMC10997934 PMID: 38585450

Article

PDF

Full Text

XML

Cited By:

0

Review Article

8. Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy

Joan Onyebuchi Erebor* , Elizabeth Oladoyin Agboluaje , Ava M. Perkins , Megha Krishnakumar, Ndidi Ngwuluka

Adv Pharm Bull. 2024;14(3): 558-573. doi: 10.34172/apb.2024.046

PMCID: PMC11530881 PMID: 39494247

Article

PDF

Full Text

XML

Cited By:

0

Review Article

9. Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment

Parisa Kangari* , Reza Salahlou, Somayeh Vandghanooni*

Adv Pharm Bull. 2024;14(3): 574-590. doi: 10.34172/apb.2024.052

PMCID: PMC11530882 PMID: 39494266

Article

PDF

Full Text

XML

Cited By:

0